Literature DB >> 1591505

What blood pressure levels should be treated?

A Zanchetti1.   

Abstract

Information concerning the level of blood pressure at which treatment should be commenced is incomplete, and current guidelines have to be considered of provisional suggestions on which many experts have a consensus. There is general agreement on the need to administer anti-hypertensive therapy when diastolic pressure is 100 mmHg or above. At diastolic values of 90-99 mmHg the risk, albeit increased, is relatively low. The wisest practical solution, which coincides with guidelines from the World Health Organization and the International Society of Hypertension, is to commence treatment if diastolic pressure is between 95 and 100 mmHg, but only after several months of observation with repeated measurements. At values between 90 and 95 mmHg, a decision in favor of treatment will be influenced by concomitant elevation of systolic values and by the occurrence of other risk factors or a strong family history of cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1591505     DOI: 10.1007/bf00207604

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  13 in total

1.  Treatment of mild hypertension: results of a ten-year intervention trial.

Authors:  W M Smith
Journal:  Circ Res       Date:  1977-05       Impact factor: 17.367

Review 2.  Antihypertensive treatment: is blood pressure-lowering the only goal?

Authors:  A Zanchetti
Journal:  J Cardiovasc Pharmacol       Date:  1991       Impact factor: 3.105

3.  Alerting reaction and rise in blood pressure during measurement by physician and nurse.

Authors:  G Mancia; G Parati; G Pomidossi; G Grassi; R Casadei; A Zanchetti
Journal:  Hypertension       Date:  1987-02       Impact factor: 10.190

4.  Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg.

Authors: 
Journal:  JAMA       Date:  1967-12-11       Impact factor: 56.272

5.  Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial.

Authors:  A Amery; W Birkenhäger; P Brixko; C Bulpitt; D Clement; M Deruyttere; A De Schaepdryver; C Dollery; R Fagard; F Forette
Journal:  Lancet       Date:  1985-06-15       Impact factor: 79.321

6.  MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-13

7.  Untreated mild hypertension. A report by the Management Committee of the Australian Therapeutic Trial in Mild Hypertension.

Authors: 
Journal:  Lancet       Date:  1982-01-23       Impact factor: 79.321

8.  Stroke and coronary heart disease in mild hypertension: risk factors and the value of treatment. Medical Research Council Working Party.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-04

9.  Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias.

Authors:  S MacMahon; R Peto; J Cutler; R Collins; P Sorlie; J Neaton; R Abbott; J Godwin; A Dyer; J Stamler
Journal:  Lancet       Date:  1990-03-31       Impact factor: 79.321

10.  The Australian therapeutic trial in mild hypertension. Report by the Management Committee.

Authors: 
Journal:  Lancet       Date:  1980-06-14       Impact factor: 202.731

View more
  1 in total

Review 1.  Cardiac rehabilitation past, present and future: an overview.

Authors:  Warner M Mampuya
Journal:  Cardiovasc Diagn Ther       Date:  2012-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.